Qube Research & Technologies LTD Syndax Pharmaceuticals Inc Transaction History

Qube Research & Technologies LTD

$93.8 Billion
Q2 2025

A detailed history of Qube Research & Technologies LTD transactions in Syndax Pharmaceuticals Inc stock. As of the latest transaction made, Qube Research & Technologies LTD holds 1,665,916 shares of SNDX stock, worth $27 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

1,665,916

Previous 834,849 99.55%

Holding current value

$27 Million

Previous $10.3 Million 52.13%

% of portfolio

0.02%

Previous 0.01%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	BUY	$8.9 - $14.15 $7.4 Million - $11.8 Million	831,067 Added 99.55%	1,665,916 $15.6 Million
Q1 2025 May 15, 2025	BUY	$12.29 - $16.38 $1.36 Million - $1.81 Million	110,433 Added 15.24%	834,849 $10.3 Million
Q4 2024 Feb 14, 2025	BUY	$12.52 - $21.81 $515,999 - $898,877	41,214 Added 6.03%	724,416 $9.58 Million
Q3 2024 Nov 14, 2024	BUY	$17.93 - $24.81 $6.92 Million - $9.57 Million	385,899 Added 129.8%	683,202 $13.2 Million
Q2 2024 Aug 14, 2024	BUY	$18.82 - $23.79 $3.83 Million - $4.84 Million	203,414 Added 216.65%	297,303 $6.1 Million
Q1 2024 May 14, 2024	BUY	$19.71 - $24.57 $719,966 - $897,492	36,528 Added 63.68%	93,889 $2.23 Million
Q4 2023 Feb 13, 2024	SELL	$11.39 - $21.67 $1.7 Million - $3.23 Million	-149,033 Reduced 72.21%	57,361 $1.24 Million
Q3 2023 Nov 13, 2023	BUY	$14.52 - $21.77 $1.1 Million - $1.65 Million	75,636 Added 57.84%	206,394 $3 Million
Q2 2023 Aug 14, 2023	BUY	$19.35 - $22.31 $1.74 Million - $2.01 Million	90,147 Added 221.98%	130,758 $2.74 Million
Q1 2023 May 15, 2023	BUY	$20.66 - $28.98 $839,023 - $1.18 Million	40,611 New	40,611 $857,000
Q2 2022 Aug 15, 2022	SELL	$13.64 - $19.48 $573,875 - $819,582	-42,073 Closed	0 $0
Q1 2022 May 09, 2022	BUY	$14.84 - $22.15 $624,363 - $931,916	42,073 New	42,073 $731,000
Q3 2020 Nov 12, 2020	SELL	$13.39 - $17.48 $279,208 - $364,492	-20,852 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$8.94 - $20.98 $186,416 - $437,474	20,852 New	20,852 $309,000

Others Institutions Holding SNDX

# of Institutions

248

Shares Held

100M

Call Options Held

1.28M

Put Options Held

1.29M

View Full List

About Syndax Pharmaceuticals Inc

Ticker SNDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,565,200
Market Cap $916M
Description
Syndax Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer. Its lead product candidates are SNDX-5613, which is in phase 1/2 clinical trial targeting the binding interaction of Menin with the mixed lineage leukemia 1 protein for the treatment of MLL-rearranged (MLLr) and nucleophosmin...

More about SNDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

News

Stay updated on Qube Research & Technologies LTD with notifications on news.

Account

Qube Research & Technologies LTD Syndax Pharmaceuticals Inc Transaction History